At the same time, the industries and institues are studying these drugs for the management of PCOS and cardiovascular diseases
Meanwhile, figures from 2023 show that slightly more than half (57%) of the GLP-1 diabetes drugs in the market are Semaglutide
Meanwhile, a renewed focus on sugary foods and beverages is gaining steam with the advent of these drugs
Research shows that without ongoing intervention, people can regain a significant portion of their lost weight within 12 months of stopping GLP-1 medication
Academic medical centers and hospital-based practices often charge higher fees than private practice endocrinologists
While both drug companies provide warning labels about common side effects of their GLP-1 medications, their labels may not provide adequate warning about severe complications such as stomach paralysis, intestinal blockages, or bowel obstruction